Your browser doesn't support javascript.
loading
VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITIS.
Pichi, Francesco; Neri, Piergorgio; Agarwal, Aniruddha; Invernizzi, Alessandro; Choudhry, Netan; Amer, Radgonde; Lembo, Andrea; Nucci, Paolo; Thompson, Ian; Sen, H Nida; Shields, Carol L.
Afiliação
  • Pichi F; Cleveland Clinic Abu Dhabi, Eye Institute, Abu Dhabi, United Arab Emirates.
  • Neri P; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.
  • Agarwal A; Cleveland Clinic Abu Dhabi, Eye Institute, Abu Dhabi, United Arab Emirates.
  • Invernizzi A; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.
  • Choudhry N; Advanced Eye Center, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Amer R; Eye Clinic, Department of Biomedical and Clinical Science 'Luigi Sacco', Luigi Sacco Hospital, University of Milan, Milan, Italy.
  • Lembo A; Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia.
  • Nucci P; Vitreous Retina Macula Specialists of Toronto, Toronto, Canada.
  • Thompson I; Hadassah Medical Center, Jerusalem, Israel.
  • Sen HN; San Giuseppe Hospital, University Eye Clinic, Milan, Italy.
  • Shields CL; San Giuseppe Hospital, University Eye Clinic, Milan, Italy.
Retina ; 40(9): 1765-1773, 2020 Sep.
Article em En | MEDLINE | ID: mdl-31584561
PURPOSE: To describe patients with intermediate uveitis complicated by vasoproliferative tumors (VPTs). METHODS: Data were collected at seven Uveitis/Ocular Oncology centers on demographic, ophthalmic findings at baseline and at follow-up, and on imaging. The therapeutic intervention, final visual acuity, and duration of follow-up were recorded. RESULTS: A total of 36 eyes from 34 patients (12 men, 22 women; mean age 35.3 ± 14.2 years) were included in this study. Visual acuity at presentation ranged from 20/40 to counting fingers. At the time of VPT diagnosis, intermediate uveitis was active in all eyes. The mean VPT thickness was 3.06 ± 0.86 mm. Local treatment to the VPT was provide in 22 eyes (61.1%) and no local treatment to the VPT in 14 eyes (38.9%). After the VPT was detected, systemic or local treatment for the inflammation was initiated and on follow-up FAs 94.4% of the eyes showed resolution of the vascular leakage. During follow-up of 35.8 months, the 22 VPTs treated locally had a reduction in the tumor thickness to 1.25 mm, whereas the 14 VPTs untreated remained stable (final mean tumor thickness 2.65 mm). CONCLUSION: The presence of active intermediate uveitis accompanied by VPTs suggests the need for an aggressive uveitis treatment.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasos Retinianos / Uveíte Intermediária / Neoplasias da Retina / Neoplasias de Tecido Vascular Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasos Retinianos / Uveíte Intermediária / Neoplasias da Retina / Neoplasias de Tecido Vascular Idioma: En Ano de publicação: 2020 Tipo de documento: Article